insights_auto
Miks on LLY80 langenud? 2,97%?
Uurige põhjalikumaltchevron_right
LLY80:BKK
Eli Lilly And Company KTB DR
1,96 ฿
arrow_downward
−2,97%(−0,060) 1 p
9. okt, 02:56:46 GMT +7 · THB
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse LLY80 põhistatistika genereerimine…
Ava
2,02 ฿
Kõrge
2,02 ฿
Madal
1,90 ฿
Turu kapit.
1,10 trln
Keskm. maht
5,07 mln
Maht
9,31 mln
52 näd kõrgeim
2,12 ฿
52 näd madalaim
1,27 ฿
Käibivad aktsiad
941,36 mln
Töötajate arv
50 tuh
Ava
2,02 ฿
Kõrge
2,02 ฿
Madal
1,90 ฿
Turu kapit.
1,10 trln
Keskm. maht
5,07 mln
Maht
9,31 mln
52 näd kõrgeim
2,12 ฿
52 näd madalaim
1,27 ฿
Käibivad aktsiad
941,36 mln
Töötajate arv
50 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
The Motley Fool
·
10 tunni eest
Eli Lilly's Obesity Business Could Become a Much Bigger Healthcare Platform
Benzinga
·
11 tunni eest
Transcript: Eli Lilly Q2 2026 Earnings Conference Call
Zacks Investment Research
·
14 tunni eest
LLY Stock Down 2% in 3 Months: Is the Dip a Buying Opportunity?
Investing.com
·
14 tunni eest
Cantor Fitzgerald raises Eli Lilly stock price target on demand trends
Profiil
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Teave üksuse Eli Lilly And Company KTB DR kohta
TegevjuhtDavid A. Ricks
Töötajad50 tuh
Asutatud1876
PeakontoridIndianapolis, Indiana, Ameerika Ühendriigid
Sektor-
Veebisaitlilly.com